PA
EGRX
Perceptive Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-173,365
| Closed | -$971K | – | 121 |
|
|
2024
Q2 | $971K | Buy |
+173,365
| New | +$971K | 0.02% | 98 |
|
|
2017
Q3 | – | Sell |
-100,000
| Closed | -$7.89M | – | 150 |
|
|
2017
Q2 | $7.89M | Buy |
+100,000
| New | +$7.89M | 0.4% | 52 |
|
|
2017
Q1 | – | Sell |
-498,198
| Closed | -$39.5M | – | 202 |
|
|
2016
Q4 | $39.5M | Sell |
498,198
-46,572
| -9% | -$3.7M | 2.81% | 10 |
|
|
2016
Q3 | $3K | Buy |
544,770
+244,770
| +82% | +$1.35K | ﹤0.01% | 184 |
|
|
2016
Q2 | $11.6M | Buy |
300,000
+112,785
| +60% | +$4.37M | 0.81% | 24 |
|
|
2016
Q1 | $7.58M | Buy |
187,215
+54,070
| +41% | +$2.19M | 0.67% | 38 |
|
|
2015
Q4 | $11.8M | Buy |
133,145
+10,101
| +8% | +$896K | 0.87% | 29 |
|
|
2015
Q3 | $9.11M | Sell |
123,044
-110,000
| -47% | -$8.14M | 0.73% | 26 |
|
|
2015
Q2 | $18.8M | Buy |
233,044
+220,956
| +1,828% | +$17.9M | 1.13% | 19 |
|
|
2015
Q1 | $506K | Buy |
+12,088
| New | +$506K | 0.04% | 106 |
|